Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer

Clinical trial NCT00303108 · COMPLETED

Trial details

NCT number: NCT00303108
Sponsor: US Oncology Research
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2005-12-01
Primary completion: 2010-03-01
Enrollment: 136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.